Oscar Health (OSCR) Short-term Investments (2020 - 2026)

Oscar Health's Short-term Investments history runs 7 years deep, the most recent figure standing at $2.0 billion for Q1 2026.

• Quarterly Short-term Investments rose 165.43% year-over-year to $2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (up 165.43% YoY) and the FY2025 annual result came in at $1.2 billion, up 94.8% from the prior year.
• Short-term Investments was $2.0 billion for Q1 2026 at Oscar Health, up from $1.2 billion in the prior quarter.
• Across five years, Short-term Investments topped out at $2.0 billion in Q1 2026 and bottomed at $363.6 million in Q2 2024.
• A 5-year average of $943.8 million and a median of $887.6 million in 2025 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments plunged 71.04% — and 2026, when it surged 165.43%.
• Oscar Health's Short-term Investments stood at $1.4 billion in 2022, then sank by 50.63% to $689.8 million in 2023, then fell by 9.48% to $624.5 million in 2024, then surged by 94.8% to $1.2 billion in 2025, then surged by 63.97% to $2.0 billion in 2026.
• Business Quant data shows OSCR's Short-term Investments at $2.0 billion in Q1 2026, $1.2 billion in Q4 2025, and $887.6 million in Q3 2025.